I got a kaplan question where one of the answer choices said "infusing EPI will preferentially stimulate b2 receptors and cause an overall decrease in DBP"
I get that, but I thought this really only applied to physiological doses of EPI (e.g. when you're exercising). Pharmacologic doses of EPI should cause an overall vasoconstrictive effect because of the overwhelming majority of a1 receptors on blood vessels, right? This is pretty much the basis behind using EPI in anaphylaxis, as well as the basis behind the experiment in the FA pharm section where they give EPI alone (vasoconstriction), and then EPI + phentolamine (vasodilation)
So I guess my question is: for the purposes of exam, should we just assume that giving an infusion of EPI will lead to overall vasoconstriction (with reflex bradycardia)?
I get that, but I thought this really only applied to physiological doses of EPI (e.g. when you're exercising). Pharmacologic doses of EPI should cause an overall vasoconstrictive effect because of the overwhelming majority of a1 receptors on blood vessels, right? This is pretty much the basis behind using EPI in anaphylaxis, as well as the basis behind the experiment in the FA pharm section where they give EPI alone (vasoconstriction), and then EPI + phentolamine (vasodilation)
So I guess my question is: for the purposes of exam, should we just assume that giving an infusion of EPI will lead to overall vasoconstriction (with reflex bradycardia)?